PHARMAPRINT INC
10-Q, EX-27.1, 2000-08-21
PHARMACEUTICAL PREPARATIONS
Previous: PHARMAPRINT INC, 10-Q, 2000-08-21
Next: FRANKLIN TEMPLETON MONEY FUND TRUST, NSAR-B, 2000-08-21



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          11,947
<SECURITIES>                                         0
<RECEIVABLES>                                  742,888
<ALLOWANCES>                                   742,888
<INVENTORY>                                  1,764,348
<CURRENT-ASSETS>                             2,301,875
<PP&E>                                         644,563
<DEPRECIATION>                               (488,255)
<TOTAL-ASSETS>                               2,448,183
<CURRENT-LIABILITIES>                       14,794,775
<BONDS>                                        117,081
                                0
                                          7
<COMMON>                                        16,831
<OTHER-SE>                                (12,480,511)
<TOTAL-LIABILITY-AND-EQUITY>                 2,448,183
<SALES>                                            420
<TOTAL-REVENUES>                                   420
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,023,680
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,453
<INCOME-PRETAX>                              (524,717)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (524,717)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (524,717)
<EPS-BASIC>                                     (0.03)
<EPS-DILUTED>                                   (0.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission